Lockheed Martin’s public market capitalization of approximately $118 billion anchors the 72.5% market-implied probability that it will hold the higher valuation on December 31, 2026. Anduril’s most recent confirmed post-money valuation stands at $61 billion following its May 2026 Series H round, though secondary-market marks and reported funding discussions have implied figures near or above $100 billion. Lockheed’s revenue base exceeds $77 billion on a trailing-twelve-month basis, dwarfing Anduril’s projected $4.3 billion for 2026, while its equity trades with established liquidity and analyst price targets above current levels. With only weeks remaining until year-end, the limited window for Anduril to complete an additional round, IPO, or revaluation that would close the gap supports the prevailing trader consensus.